IL6 and Cerebral ischemia: CA has demonstrated its importance as an effective inhibitor of 5-lipooxygenase (5-LO) and it has proven its capacity to diminish NF-κB, Interleukin-6 (IL-6), and IL-1β levels during inflammatory processes, especially global cerebral ischemia-reperfusion injuries in rats [46].